Content Type: Research Publications

Sales Revenues for New Therapeutic Agents Approved by the United States Food and Drug Administration from 1995 to 2014

March 6, 2026

Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention

March 6, 2026

Vaccine Messaging By the FDA: A National Randomized Survey Study

March 6, 2026

Shortages of Essential Generic Drugs with Limited Competition

March 6, 2026

Trust in the Food and Drug Administration: A National Survey Study

March 6, 2026

Biosimilar Uptake in the US: Patient and Prescriber Factors

March 6, 2026

Clinical Value of Guideline Recommended Molecular Targets and Genome Targeted Cancer Therapies: Cross Sectional Study

March 6, 2026

Emulating Randomized Trials By Observational Database Studies: The RCT-DUPLICATE Initiative in COPD and Asthma

March 6, 2026

Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020

March 6, 2026

Patient Perspectives on Evidence Supporting Drug Safety and Effectiveness: “What Does It Mean for Me?”

March 6, 2026

Commercial Markups on Pediatric Oncology Drugs at 340B Pediatric Hospitals

March 6, 2026

Availability and Cost of Expensive and Common Generic Prescription Drugs: A Cross-Sectional Analysis of Direct-To-Consumer Pharmacies

March 6, 2026